Keyphrases
Pulmonary Embolism
100%
Right Ventricular Function
100%
Diclofenac
100%
Confidence Interval
44%
Placebo Groups
33%
Placebo
33%
Acute Pulmonary Embolism
33%
Major Bleeding
22%
Anticoagulation
22%
Group Differences
11%
Potential Gains
11%
Two-dose
11%
Unique Identifier
11%
Clinical Trial Registry
11%
Echocardiographic
11%
Right Ventricular
11%
Inflammatory Response
11%
Efficacy Outcomes
11%
Safety Outcomes
11%
Left Ventricle
11%
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
11%
Primary Safety
11%
Right Ventricular Free Wall
11%
Intention-to-treat Analysis
11%
Low Molecular Weight Heparin
11%
Systemic Blood Pressure
11%
Oral Vitamin K Antagonists
11%
Pulmonary Artery Systolic Pressure
11%
Subcostal
11%
Parasternal
11%
Hypokinesia
11%
Right Ventricular Diameter
11%
Medicine and Dentistry
Pulmonary Embolism
100%
Heart Right Ventricle Function
100%
Diclofenac
100%
Placebo
66%
Acute Pulmonary Embolism
33%
Major Bleeding
22%
Anticoagulation
22%
Serositis
11%
Clinical Trial
11%
Systolic Blood Pressure
11%
Blood Pressure
11%
Pulmonary Artery
11%
Intention-to-Treat Analysis
11%
Left Ventricle
11%
Nonsteroid Antiinflammatory Agent
11%
Vitamin K Antagonist
11%
Low Molecular Weight Heparin
11%
Hexachlorophene
11%
Hypokinesia
11%
Oral
11%
Pharmacology, Toxicology and Pharmaceutical Science
Lung Embolism
100%
Diclofenac
100%
Placebo
75%
Bleeding
25%
Clinical Trial
12%
Inflammation
12%
Non-Steroidal Anti-Inflammatory Drug
12%
Hexachlorophene
12%
Low Molecular Weight Heparin
12%
Antivitamin K
12%
Hypokinesia
12%
Neuroscience
Pulmonary Embolism
100%
Diclofenac
100%
Placebo
75%
Non-Steroidal Anti-Inflammatory Drug
12%
Pulmonary Artery
12%
Low Molecular Weight Heparin
12%
Vitamin K Antagonist
12%